Human CD160, recombinant (C-6His)

Human CD160, recombinant (C-6His)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NOV-CA35.10ug 10 µg - -

10 - 15 Werktage*

50,00 €
NOV-CA35.50ug 50 µg - -

10 - 15 Werktage*

140,00 €
NOV-CA35.500ug 500 µg - -

10 - 15 Werktage*

615,00 €
NOV-CA35.1mg 1 mg - -

10 - 15 Werktage*

880,00 €
 
Recombinant Human CD160 is produced by our Mammalian expression system and the target gene... mehr
Produktinformationen "Human CD160, recombinant (C-6His)"
Recombinant Human CD160 is produced by our Mammalian expression system and the target gene encoding Ile27-Ser159 is expressed with a 6His tag at the C-terminus. Protein function: [CD160 antigen]: Receptor on immune cells capable to deliver stimulatory or inhibitory signals that regulate cell activation and differentiation. Exists as a GPI-anchored and as a transmembrane form, each likely initiating distinct signaling pathways via phosphoinositol 3-kinase in activated NK cells and via LCK and CD247/CD3 zeta chain in activated T cells (PubMed:19109136, PubMed:11978774, PubMed:17307798). Receptor for both classical and non-classical MHC class I molecules (PubMed:9973372, PubMed:12486241). In the context of acute viral infection, recognizes HLA-C and triggers NK cell cytotoxic activity, likely playing a role in anti-viral innate immune response (PubMed:12486241). On CD8+ T cells, binds HLA-A2-B2M in complex with a viral peptide and provides a costimulatory signal to activated/memory T cells (PubMed:9973372). Upon persistent antigen stimulation, such as occurs during chronic viral infection, may progressively inhibit TCR signaling in memory CD8+ T cells, contributing to T cell exhaustion (PubMed:25255144). On endothelial cells, recognizes HLA-G and controls angiogenesis in immune privileged sites (PubMed:16809620). Receptor or ligand for TNF superfamily member TNFRSF14, participating in bidirectional cell-cell contact signaling between antigen presenting cells and lymphocytes. Upon ligation of TNFRSF14, provides stimulatory signal to NK cells enhancing IFNG production and anti-tumor immune response. On activated CD4+ T cells, interacts with TNFRSF14 and downregulates CD28 costimulatory signaling, restricting memory and alloantigen-specific immune response (PubMed:18193050). In the context of bacterial infection, acts as a ligand for TNFRSF14 on epithelial cells, triggering the production of antimicrobial proteins and proinflammatory cytokines. [The UniProt Consortium]
Schlagworte: Recombinant Human CD160 (C-6His)
Hersteller: Novoprotein
Hersteller-Nr: CA35

Eigenschaften

Konjugat: No
Wirt: Human cells
Spezies-Reaktivität: human
MW: 15.8 kD
Format: Lyophilized

Datenbank Information

KEGG ID : K06542 | Passende Produkte
UniProt ID : O95971 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C (+4 °C for short term storage)
Versand: +20°C (International: +20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Human CD160, recombinant (C-6His)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen